Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tetanus Vaccine”

416 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 416 results

Testing effectiveness (Phase 2)Study completedNCT00938223
What this trial is testing

Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma

Who this might be right for
Melanoma
Craig L Slingluff, Jr 51
Not applicableLooking for participantsNCT07358910
What this trial is testing

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Who this might be right for
DengueChikungunyaZika Virus Infection+55 more
Institut Pasteur du Cambodge 10,000
Large-scale testing (Phase 3)Study completedNCT01062477
What this trial is testing

DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Sanofi 1,056
Not applicableStudy completedNCT01890850
What this trial is testing

Study to Analyze the Risk Factors Associated With Pertussis/Whooping Cough Infection Among Infants

Who this might be right for
DiphtheriaAcellular PertussisTetanus
GlaxoSmithKline 1
Large-scale testing (Phase 3)Study completedNCT00518180
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents

Who this might be right for
Meningococcal MeningitisHuman Papillomavirus InfectionPertussis+1 more
Novartis Vaccines 1,620
Testing effectiveness (Phase 2)Study completedNCT02587520
What this trial is testing

Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects

Who this might be right for
TetanusDiphtheriaPertussis+1 more
Sanofi Pasteur, a Sanofi Company 1,363
Large-scale testing (Phase 3)Study completedNCT01086423
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine

Who this might be right for
TetanusPoliomyelitisAcellular Pertussis+2 more
GlaxoSmithKline 985
Large-scale testing (Phase 3)Study completedNCT01287949
What this trial is testing

Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older

Who this might be right for
DiphtheriaTetanusPoliomyelitis+1 more
Sanofi Pasteur, a Sanofi Company 342
Not applicableLooking for participantsNCT07347938
What this trial is testing

Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Following Injury

Who this might be right for
Tetanus
Zhuhai Trinomab Pharmaceutical Co., Ltd. 6,000
Large-scale testing (Phase 3)Study completedNCT06049940
What this trial is testing

Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old Population

Who this might be right for
Tetanus
Sinovac Life Sciences Co., Ltd. 1,260
Not applicableStudy completedNCT01691651
What this trial is testing

Botulinum Toxin A for the Treatment of Keratoconus

Who this might be right for
Keratoconus
Federal University of São Paulo 40
Post-approval studies (Phase 4)Study completedNCT06588530
What this trial is testing

PFAS Exposure and Immune Response to Vaccination in Adults

Who this might be right for
Innate Inflammatory ResponseVaccinationDiphtheria+7 more
Rutgers, The State University of New Jersey 20
Post-approval studies (Phase 4)Study completedNCT00392808
What this trial is testing

Immunogenicity of the Booster Dose of Two MenC Vaccines

Who this might be right for
Meningococcal Infection
Centro Superior de Investigación en Salud Publica 389
Not applicableStudy completedNCT00908115
What this trial is testing

Post Market Surveillance for Infanrix™

Who this might be right for
DiphtheriaAcellular PertussisTetanus
GlaxoSmithKline 1,258
Very early researchUnknownNCT06360250
What this trial is testing

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Fully Human Anti-tetanus Toxin Monoclonal Antibody A82 / B86 Injection Combination Formulation

Who this might be right for
Clostridium Tetanus
Changchun BCHT Biotechnology Co. 190
Testing effectiveness (Phase 2)Study completedNCT00158808
What this trial is testing

Immune Memory Foll Pry Vaccination With DTPw-HBV/Hib Vaccine Formulation; Immuno & Reacto of Booster Dose at 15-18 Mths

Who this might be right for
Hib DiseaseHepatitis BPertussis+2 more
GlaxoSmithKline 175
Not applicableStudy completedNCT03266211
What this trial is testing

Antitetanus Vaccination for People Older Than 65 Years.

Who this might be right for
Tetanus
Hospices Civils de Lyon 261
Post-approval studies (Phase 4)Study completedNCT01094171
What this trial is testing

Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia

Who this might be right for
Poliomyelitis
GlaxoSmithKline 400
Large-scale testing (Phase 3)Study completedNCT00432042
What this trial is testing

Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035)

Who this might be right for
VaricellaMeaslesMumps+7 more
Merck Sharp & Dohme LLC 955
Testing effectiveness (Phase 2)Study completedNCT03566940
What this trial is testing

Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization Schedule

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 302
Next Page